Cargando…

PReS-FINAL-2267: Successful treatment of pulmonary arterial hypertension associated with connective tissue disease (PAH-CTD) with combination therapy of sildenafil and ambrisentan: a case report

Detalles Bibliográficos
Autores principales:	Yamaguchi, KI, Kishimoto, M, Okada, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044944/ http://dx.doi.org/10.1186/1546-0096-11-S2-P257

Ejemplares similares

Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial
por: Coghlan, John Gerry, et al.
Publicado: (2017)

Pharmacokinetic and Pharmacodynamic Comparison of Sildenafil‐Bosentan and Sildenafil‐Ambrisentan Combination Therapies for Pulmonary Hypertension
por: Hakamata, A, et al.
Publicado: (2016)

Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis
por: Kuwana, Masataka, et al.
Publicado: (2020)

Correction: Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis
Publicado: (2020)

Egln1(Tie2Cre) Mice Exhibit Similar Therapeutic Responses to Sildenafil, Ambrisentan, and Treprostinil as Pulmonary Arterial Hypertension (PAH) Patients, Supporting Egln1(Tie2Cre) Mice as a Useful PAH Model
por: Peng, Yi, et al.
Publicado: (2023)

Economic burden of illness among patients with pulmonary arterial hypertension (PAH) associated with connective tissue disorders (CTD)
por: Tsang, Yuen, et al.
Publicado: (2023)

PReS-FINAL-1010: circulating micrornas in traps
por: Lucherini, OM, et al.
Publicado: (2013)

PReS-FINAL-2220: Cochlear involvement in FMF
por: Keskindemirci, G, et al.
Publicado: (2013)

PReS-FINAL-2221: An earliest diagnosis of FMF
por: Keskindemirci, G, et al.
Publicado: (2013)

2267 Radiofrequency renal denervation attenuates kidney fibrosis in spontaneously hypertensive rats
por: Gao, Juan, et al.
Publicado: (2018)

A randomized, double-blind, placebo-controlled study to evaluate sildenafil, ambrisentan combination therapy in pulmonary hypertension, particularly of Eisenmenger syndrome
por: Mohammed, Shaadab, et al.
Publicado: (2021)

Connecting The Dots (CTD 2022)
Publicado: (2022)

Connecting The Dots (CTD 2023)
por: Annovi, Alberto, et al.
Publicado: (2023)

Ambrisentan for the treatment of pulmonary arterial hypertension
por: Casserly, Brian, et al.
Publicado: (2009)

PReS-FINAL-2210: Qualitative aspects of autoinflammatory diseases
por: Konukbay, D, et al.
Publicado: (2013)

PReS-FINAL-2259: Spectrum of Sjögren syndrome in children
por: Bica, BE, et al.
Publicado: (2013)

PReS-FINAL-2087: Diagnosis of arthritis: history or laboratory?
por: Yurtsever, O, et al.
Publicado: (2013)

PReS-FINAL-2219: Evaluation of autonomic function in FMF
por: Aktay Ayaz, N, et al.
Publicado: (2013)

PReS-FINAL-2222: FMF presenting with the features of malignancy
por: Keskindemirci, G, et al.
Publicado: (2013)

PReS-FINAL-2124: Electromyography assessment in localized scleroderma
por: Fernandes, TP, et al.
Publicado: (2013)

PReS-FINAL-2131: Hunting for biomarkers in juvenile dermatomyositis
por: Bellutti Enders, F, et al.
Publicado: (2013)

PReS-FINAL-2327: Abatacept in the treatment of refractory uveitis
por: Moretti, D, et al.
Publicado: (2013)

PReS-FINAL-2366: Paediatric rheumatology in South Africa
por: Scott, C
Publicado: (2013)

PReS-FINAL-2330: Canakinumab treatment in patients with HIDS
por: Antón, J, et al.
Publicado: (2013)

PReS-FINAL-2234: Successful canakunimab treatment in uveitis secondary to cryopyrin-associated periodic syndrome
por: Kasapcopur, O, et al.
Publicado: (2013)

Connecting The Dots 2020 (CTD 2020)
por: Lange, David
Publicado: (2020)

PReS-FINAL-2277: Clubbing fingers in a boy with arthritis
por: Giani, T, et al.
Publicado: (2013)

PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients
por: Hofer, F, et al.
Publicado: (2013)

PReS-FINAL-2331: Low-penetrance NLRP3 variants
por: Endres, T, et al.
Publicado: (2013)

PReS-FINAL-2217: Atypical presentation of CRMO in two children
por: Vanoni, F, et al.
Publicado: (2013)

PReS-FINAL-2006: Resilience and coping in adolentes with rheumatic illness
por: Alessio, M, et al.
Publicado: (2013)

PReS-FINAL-2227: QT and JT dispersion in children with FMF
por: Fidanci, K, et al.
Publicado: (2013)

PReS-FINAL-2208: Sacroilitis with propionibacterium acnes in a child
por: Galeotti, C, et al.
Publicado: (2013)

PReS-FINAL-2127: Sclerodermatous graft versus host disease
por: Stevenson, JR, et al.
Publicado: (2013)

PReS-FINAL-2336: Induction of MDSCS in Muckle-Wells syndrome
por: Rieber, N, et al.
Publicado: (2013)

PReS-FINAL-2049: Bone health, muscle strength, activity
por: Sandstedt, E
Publicado: (2013)

PReS-FINAL-2337: The eurofever registry: 3 years of enrollment
por: Federici, S, et al.
Publicado: (2013)

PReS-FINAL-2254: Is it systemic JIA or post infectious illness?
por: Guddeti, P, et al.
Publicado: (2013)

PReS-FINAL-2106: Clinical psoriatic arthritis of specific children
por: Chebisheva, S, et al.
Publicado: (2013)

PReS-FINAL-2025: Arthritis associated with human immunodeficiency virus
por: Bean, AE, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lo6cv50fnbq7131eppaf7qe5r7